Antifungal pharmacodynamics: Concentration-effect relationships in vitro and in vivo

A. H. Groll, S. C. Piscitelli, T. J. Walsh

Research output: Contribution to journalReview article

Abstract

The pharmacodynamics of antifungal compounds involve relationships among drug concentrations, time, and antimicrobial effects in vitro and in vivo. Beyond better understanding of a drug's mode of action, characterization of these relationships has important implications for setting susceptibility breakpoints, establishing rational dosing regimens, and facilitating drug development. Important advances have been made in the experimental investigation of pharmacokinetics and pharmacodynamics of antifungal drugs; however, much remains to be learned about specific pathogens and specific sites of infection. Increased incorporation of pharmacokinetic and pharmacodynamic principles in experimental and clinical studies with antifungal agents is an important objective that will benefit the treatment and prophylaxis of life-threatening invasive fungal infections in immunocompromised patients.

Original languageEnglish (US)
Pages (from-to)133S-148S
JournalPharmacotherapy
Volume21
Issue number8 SUPPL. 2
DOIs
StatePublished - 2001

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Antifungal pharmacodynamics: Concentration-effect relationships in vitro and in vivo'. Together they form a unique fingerprint.

  • Cite this